News Releases

News Releases

Prometheus Biosciences Announces Upsized Pricing of Initial Public Offering

Mar 11, 2021
SAN DIEGO, March 11, 2021 / PRNewswire / -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory

Prometheus Biosciences Appoints Joseph C. Papa to its Board of Directors

Aug 25, 2020
SAN DIEGO, Aug. 25, 2020 / PRNewswire / — Prometheus Biosciences, Inc., (“Prometheus”) a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with Inflammatory

Prometheus Biosciences Appoints Keith W. Marshall as Chief Financial Officer

Aug 04, 2020
SAN DIEGO, August 4, 2020 / PRNewswire / — Prometheus Biosciences, Inc., (“Prometheus”) a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with Inflammatory
Displaying 31 - 40 of 41